Ana I. Sánchez Fructuoso-rekin lankidetzan egindako argitalpenak (4)

2022

  1. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study

    Clinical transplantation, Vol. 36, Núm. 3, pp. e14550

2020

  1. Monitoring of Donor-specific Anti-HLA Antibodies and Management of Immunosuppression in Kidney Transplant Recipients: An Evidence-based Expert Paper

    Transplantation, Vol. 104, Núm. 8 2S Suppl 2, pp. S1-S12

2011

  1. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients

    American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971

2006

  1. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain

    Clinical Transplantation, Vol. 20, Núm. 5, pp. 650-658